April 21st – 22nd, 2023, at the Westin Hotel in Atlanta, Georgia.
Some of this year’s topics will include:
- Xenotransplantation: Cross-Species Renal Transplantation and the Potential Alleviation of Shortages in Viable Organs
- Disease Expression of APOL-1 in the Kidney: Pathophysiologic Mechanisms for Glomerular, “The Impact of APOL1 on Chronic Kidney Disease and Hypertension”
- Review of Kidney Health Care Initiative-Productive Collaboration between NIH and Industry
- C3 Glomerulopathy and Dense Deposit Disease: Pathophysiology and Role of Factor D Inhibition
- Thrombotic Microangiopathies: Role of Complement Activation-Disease Manifestations and Novel Therapies
- Endotoxin and Cytokines: Mediators of the Septic Condition-Efficacy of Extracorporeal Clearance in the ICU
- Podocyte Biology: Pathophysiology and Therapeutic Attempts to Activate Glomerular Regeneration
- Low Protein Diet and CKD: New Insights and Re-Emergence of Old Concept
- Renal Pathology Wars: “Who is Right and Who is Humiliated”-Team Tumlin vs. Team Rovin
Our objective is to facilitate collaboration between practicing physicians, clinical trial professionals and industry. We expect upwards of 100 MDs and NPs in attendance, and therefore have designed the session to be highly interactive, including extended Q/A sessions to maximize learnings.
Mark your calendars! Click the registration button for Early Bird Registration savings!
12 AMA PRA Category 1 Credits™
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12 MOC points ABIM MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of Georgia through the joint provider ship of Southern Alliance for Physician Specialties CME and NephroNet. The Southern Alliance for Physician Specialties CME is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.
The Southern Alliance for Physician Specialties CME designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: For the 2023 event MOC credit is available if requested and necessary credentials provided by the physician prior to the event.
Mineralocorticoid Escape: Is it real?
Is it important in diabetic kidney disease?
A lecture by the esteemed:
Andrew S. Bomback, MD
Assistant Professor of Medicine at CUMC, Director of Clinical Research, Division of Nephrology, New York Presbyterian/Columbia University Irving Medical Center
James A. Tumlin, MD
Professor of Medicine at Emory School of Medicine, Nephrologist at Georgia Nephrology, President of NephroNet
Pre-recorded video of the webinar is available under the videos tab at the top.
A core mission of the NephroNet organization
is to provide medical education to the nephrology community through educational seminars that connect the latest basic research with the clinical practice of nephrology.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of Georgia through the joint providership of Southern Alliance for Physician Specialties CME and NephroNet, Inc. The Southern Alliance for Physician Specialties CME is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.
The Southern Alliance for Physician Specialties CME designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NephroNet is an organization dedicated to providing resources to patients, practicing clinicians, and all individuals that are concerned with improving the care of patients with kidney disease. For patients, our goal is to be an educational resource that provides practical information to patients and their families. We endorse and are motivated as an organization to improve minority participation in CKD clinical research. We believe that by improving patient education of their disease, they will be better equipped to work with their physicians.
The NephroNet membership is composed of both academic and private physicians that work closely with the National Institutes of Health (NIH), American Society Nephrology, as well as large and small healthcare companies that are motivated to treat chronic kidney disease. The NephroNet membership has experts in all areas of kidney disease and is available for consultation that will ultimately bring new therapies to the renal community.
Our 2023 Sponsors
We help industry sponsors connect with lead investigators and clinical trial services in nephrology. Ready to get started? Let us help you put all the pieces together to take you from proof of concept to regulatory approval.
Understanding your options is the biggest hurdle. Learning more about your kidney condition is the first step.
Looking for help from a leading expert? Or want assistance writing your trial protocol? NephroNet is dedicated to provide resources to serve you and your patients.
Our team of experts provides you with the required scientific, therapeutic, and regulatory expertise to design studies for new drugs for the treatment of chronic kidney disease.
The battle debate between the esteemed,
James Tumlin, MD & Brad Rovin, MD.